EuroSciCon Ltd. is proud to host the Conference on Virology (Virology-2018) taking place on June 21-22, 2018 Paris, France. The conference is themed around “From Viruses to Viromes” with the aim to bring together a wide audience of industry, healthcare, research, and medical practitioners to educate and bring about a fruitful debate on the confined topics. The Virology 2018 will be a great event to network, learn and engage with professionals in the field of infectious diseases, microbiology and virology.
For abstract submissions, please follow this link.
For conference details, please visit:
The American Society for Virology is a 501(c)(3) nonprofit that promotes the exchange of information and stimulates discussion and collaboration among virologists. The purpose of the Society is the advancement and promulgation of knowledge relevant to virology.
For more information about the ASV Annual Meeting please visit
The International Foamy Virus Meetings are an important forum for participants from all over the world to discuss their latest results in the field of foamy viruses and related retroviruses and represents a valuable opportunity for networking and collaborating. We invite you to submit until June 15th high quality abstracts for oral presentations on the following scientific topics:
• Epidemiology of Natural and Zoonotic Infections
• Interaction of Foamy Viruses with the Immune System
• Molecular and Cellular Biology of the Foamy Virus Replication Strategy
• Mechanisms of Virus – Host Cell Interactions
• Structural Studies of Foamy Virus Proteins
• Development of Foamy Virus Gene Transfer and Genome Editing Tools
• Application of Foamy Virus Vectors for Gene Therapy Treatment Strategies
Our invited Keynote Speakers will be,
• Prof. Welkin Johnson, Chair Biology Department, Boston College, USA
• Prof. Frank Buchholz, Medical Systems Biology, University Cancer Center TU Dresden, Germany
The Institute of Virology at the Medical Faculty Carl Gustav Carus of the Technische Universität Dresden is very pleased to welcome you to the 12th International Foamy Virus Meeting from August 30th to 31st, 2018
Please find more information on our meeting website
Like their cellular hosts, invading viral pathogens that depend upon the host cell nuclear machinery are also subject to the regulatory impacts of chromatin.
For lytic pathogens, successful infection depends upon the ability to counter cellular defense mechanisms that can result in suppressive heterochromatin assembled on the viral genome along with utilization of cellular chromatin modulation activities that promote efficient viral gene transcription and DNA replication. Additionally, viral pathogens whose complex replication cycles include coupled stages of lytic replication and latency/persistence are impacted by epigenetic modulation that plays a controlling role in determining the viral state.
Research into the basic biology of chromatin deposition, modification, and modulation/remodeling will contribute to the understanding of the complex host-viral interactions that influence the progression of viral diseases. Additionally, insights into the role of epigenetic machinery in controlling viral infection can present novel opportunities for prophylaxis or treatment. The workshop "2018 Chromatin Control of Viral Infection" will focus on epigenetic mechanisms that regulate viral chromatin states, viral encoded factors that modulate viral and/or cellular chromatin, and epigenetic control of host cell antiviral responses.
We invite you to participate in this intimate symposium-workshop.
Registration and additional information online at:
We are proud to announce the 5th edition of the International HBV Cure Workshop 2018, which will take place on 7 November 2018 in Toronto, Canada.
More than 250 million people are chronically infected with hepatitis B (HBV) around the globe. The purpose of the program is to inform the participants about the developments in the possibilities to find a cure for HBV. The meeting will be highly interactive with input from experts out of the arena of basic, translational and clinical HBV research. The field of HBV treatment is undergoing major changes and is on the verge of a paradigm shift. The many new treatment options that are becoming available are providing great hopes for decreasing the burden of the disease, simplifying treatment and ultimately curing and eradicating HBV infection. In order to optimize curative treatment for HBV, outstanding speakers from around the globe will share the newest therapeutic options for viral hepatitis and experts will discuss the path forward to cure this deadly disease, leading to liver cirrhosis and liver cancer. Questions on which end points to use in therapeutic trials and how to combine different agents targeting the virus and/or immune system will be extensively discussed. This workshop also brings together global interdisciplinary experts to provide a framework for how academia and industry should could collaborate to achieve the goal of curing hepatitis B.